CC
OCUL icon

Courier Capital’s Ocular Therapeutix OCUL Stock Holding History

Courier Capital’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$708K Hold
72,104
– – 0.04% 246
2026
Q1 		$611K Buy
72,104
+2,000
+3% +$19.1K 0.03% 250
2025
Q4 		$851K Sell
70,104
-66,162
-49% -$804K 0.05% 225
2025
Q3 		$1.59M Sell
136,266
-18,000
-12% -$215K 0.09% 182
2025
Q2 		$1.43M Hold
154,266
– – 0.09% 188
2025
Q1 		$1.13M Buy
154,266
+97,828
+173% +$752K 0.07% 197
2024
Q4 		$482K Buy
+56,438
New +$551K 0.03% 261

Other funds holding OCUL

PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
RZH
Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Courier Capital's OCUL Position: Q2 2026 in Review

Courier Capital held its Ocular Therapeutix (OCUL) position steady in Q2 2026 at 72,104 shares worth $708K. The position accounts for 0.04% of the portfolio, ranked #246.

Courier Capital first reported a position in OCUL in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.59M in Q3 2025. 21 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Courier Capital held 72,104 shares of Ocular Therapeutix worth $708K as of Q2 2026.
  • Courier Capital left its Ocular Therapeutix share count unchanged in Q2 2026.
  • Ocular Therapeutix made up 0.04% of Courier Capital's portfolio in Q2 2026, its #246 holding.
  • Courier Capital first reported a position in Ocular Therapeutix in Q4 2024 and has held it in 7 quarters since.
  • Courier Capital's Ocular Therapeutix position peaked at $1.59M in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.